These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 164066)

  • 21. Studies of thymus-derived and bone marrow-derived lymphocytes in renal transplant patients.
    Thomas F; Owens L; Lee HM; Wolf JS; Thomas J; Mendez G; Volk M
    Am Surg; 1975 Nov; 41(11):738-44. PubMed ID: 1103670
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The significance of immunologic mechanisms in the pathogenesis of renal diseases. 2. Immune complex nephritis, cell mediated reactions, pyelonephritis, therapeutic possibilities and conclusions].
    Ludwig H; Schernthaner G
    Med Klin; 1978 May; 73(19):691-703. PubMed ID: 349332
    [No Abstract]   [Full Text] [Related]  

  • 23. [Possibilities and current trends of biological immunosuppression in organ and tissue transplantation. I].
    Păuşescu E
    Microbiol Parazitol Epidemiol (Bucur); 1973; 18(5):437-58. PubMed ID: 4588358
    [No Abstract]   [Full Text] [Related]  

  • 24. Skin allograft survival in lymphocyte-depleted calves.
    Chanana AD; Cronkite EP; Joel DD; Schiffer LM
    Transplant Proc; 1969 Mar; 1(1):583-5. PubMed ID: 4944274
    [No Abstract]   [Full Text] [Related]  

  • 25. [Salvage therapy with anti-IL-2 receptor antibodies in high-risk kidney transplant patients].
    Carl S; Wiesel M; Deiss JM; Daniel V; Opelz G; Staehler G
    J Urol (Paris); 1997; 103(1-2):7-9. PubMed ID: 9765770
    [No Abstract]   [Full Text] [Related]  

  • 26. Induction of stable long-term mixed hematopoietic chimerism following nonmyeloablative conditioning with T cell-depleting antibodies, cyclophosphamide, and thymic irradiation leads to donor-specific in vitro and in vivo tolerance.
    Mapara MY; Pelot M; Zhao G; Swenson K; Pearson D; Sykes M
    Biol Blood Marrow Transplant; 2001; 7(12):646-55. PubMed ID: 11787527
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lymphocyte responsiveness in cancer and transplantation.
    McKhann CF; Slade MS; Gunnarsson A; Burk MW
    Transplant Proc; 1975 Jun; 7(2):287-90. PubMed ID: 1093297
    [No Abstract]   [Full Text] [Related]  

  • 28. [Clinical heart transplantation. Orientation after 10 years].
    Struck E; Meisner H; Hagl S; Mendler N; Schmidt-Habelmann P; Sebening F
    Med Klin; 1978 Mar; 73(13):435-46. PubMed ID: 345075
    [No Abstract]   [Full Text] [Related]  

  • 29. [Immunosuppression by means of antilymphocyte serums in humans].
    Revillard JP
    Nouv Rev Fr Hematol; 1972; 12(2):129-37. PubMed ID: 4264610
    [No Abstract]   [Full Text] [Related]  

  • 30. Progesteroids as immunosuppressive agents.
    Munroe JS
    J Reticuloendothel Soc; 1971 Apr; 9(4):361-75. PubMed ID: 4323974
    [No Abstract]   [Full Text] [Related]  

  • 31. An overview of steroids in transplantation and glomerular disease.
    Merrill JP
    Transplant Proc; 1975 Mar; 7(1):7-10. PubMed ID: 164068
    [No Abstract]   [Full Text] [Related]  

  • 32. Immunosuppressive effects of specific classes of agents with special reference to organ transplantation. Immunosuppression by thiopurines.
    Zweiman B
    Transplant Proc; 1973 Sep; 5(3):1197-201. PubMed ID: 4580719
    [No Abstract]   [Full Text] [Related]  

  • 33. Immunosuppression with cyclophosphamide in the dog.
    Putnam CW; Halgrimson CG; Groth CG; Kashiwagi N; Porter KA; Starzl TE
    Clin Exp Immunol; 1975 Nov; 22(2):323-9. PubMed ID: 765024
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of mixed lymphocyte culture by alloantibodies in renal transplantation and in pregnancy.
    Revillard JP; Robert M; DuPont E; Betuel H; Rifle G; Traeger J
    Transplant Proc; 1973 Mar; 5(1):331-5. PubMed ID: 4266656
    [No Abstract]   [Full Text] [Related]  

  • 35. Kidney transplantation for patients with diabetes mellitus.
    Najarian JS; Henriksen AI; Simmons RL; Kjellstrand CM
    Transplant Proc; 1974 Dec; 6(4 Suppl 1):121-7. PubMed ID: 4612898
    [No Abstract]   [Full Text] [Related]  

  • 36. The clinical relevance of pretransplant recipient immunoresponsiveness in renal transplantation: impact on rejection.
    Renna Molajoni E; Cinti P; Evangelista B; Poli L; Cocciolo P; Berloco P; Cortesini R
    Transplant Proc; 1996 Feb; 28(1):402-3. PubMed ID: 8644290
    [No Abstract]   [Full Text] [Related]  

  • 37. Recognition and treatment of rejection in experimental and human lung allografts.
    Veith FJ; Koerner SK; Siegelman SS; Lalezari P; Torres M; Chandler P; Kawakami M; Hagstrom JW; Gliedman ML
    Transplant Proc; 1973 Mar; 5(1):783-6. PubMed ID: 4572140
    [No Abstract]   [Full Text] [Related]  

  • 38. Current status of clinical cardiac transplantation.
    Lower RR
    Transplant Proc; 1974 Dec; 6(4 Suppl 1):107-13. PubMed ID: 4280167
    [No Abstract]   [Full Text] [Related]  

  • 39. Clinical evaluation of the immunogenicity of horse and rabbit antihuman lymphocyte globulin in renal transplantation.
    Cerilli GJ; Miller A; Hattan D
    Surg Forum; 1970; 21():250-2. PubMed ID: 4936976
    [No Abstract]   [Full Text] [Related]  

  • 40. Skin and renal rabbit allograft rejection following large pulse doses of methylprednisolone.
    Friedman EA; Beyer MM
    Transplant Proc; 1975 Mar; 7(1):67-72. PubMed ID: 1091047
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.